BioTelemetry, Inc.
BioTelemetry, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The stock has a good momentum. BioTelemetry, Inc. is not very popular among insiders. BioTelemetry, Inc. is a good stock to invest in, but there are better stocks to choose.
Log in to see more information.
BioTelemetry, Inc. provides monitoring services and digital population health management in a health...
News
HeartBeam names Cruickshank as finance chief
SeekingAlpha.com: All News HeartBeam (BEAT) appoints Timothy Cruickshank as CFO, succeeding Richard Brounstein.\n more…
HeartBeam Names Timothy Cruickshank as Chief Financial Officer
Business Wire HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, announced the appointment of Timothy...\n more…
HeartBeam, Inc. 2024 Q2 - Results - Earnings Call Presentation
SeekingAlpha HeartBeam, Inc. 2024 Q2 - Results - Earnings Call Presentation...\n more…
HeartBeam, Inc. (BEAT) Q2 2024 Earnings Call Transcript
Seeking Alpha: Transcripts HeartBeam, Inc. (BEAT) Q2 2024 Earnings Call Transcript...\n more…
